Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Siemens Showcases Broad Portfolio of Infectious Disease Testing Capabilities at ECCMID 2012

Published: Monday, April 16, 2012
Last Updated: Monday, April 16, 2012
Bookmark and Share
Company exhibit featured the latest in liver health, microbiology and molecular diagnostic solutions.

Siemens Healthcare Diagnostics has showcased its broad portfolio of infectious disease testing capabilities¹ — from screening and diagnosis to susceptibility testing, genotyping, therapy selection and monitoring — at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in London. The Siemens solutions on display at ECCMID 2012 reinforced the company's commitment to the development of reliable, high-quality infectious disease diagnostic solutions to help laboratories optimise workflow and enhance operational efficiency.

The exhibit — themed “Innovation. Powered for Infectious Disease Solutions.”— featured innovative products designed to address the current and growing demands of infectious disease testing, including customised workflow options, assays to help clinicians improve patient care, and clinically-validated, expert-based software solutions that support personalised medicine.

“Infectious disease is a leading cause of death worldwide2, making it critical that clinicians have access to diagnostic solutions that provide trustworthy results, which ultimately contribute to optimal patient outcomes,” said Christoph Gauer, PhD, CEO, Molecular and Microbiology Business Segment at Siemens Healthcare Diagnostics. “Visitors to our ECCMID booth learnt how Siemens can help them improve the delivery of vital information healthcare providers require to care for their patients impacted by infectious disease.”

Liver Health Solutions

The Siemens ECCMID exhibit provided a platform to showcase the company’s portfolio of diagnostic solutions for managing liver-disease patients, including routine chemistry tests, hepatitis serology assays, viral load testing and ultrasound systems. A key highlight was the recently launched ADVIA Centaur® ELF™ Test3, the first routine standardised direct biomarker panel for the assessment of liver fibrosis, a leading indicator of chronic liver disease, such as cirrhosis and liver cancer. With results provided in about an hour, the ELF test combines three serum biomarkers—hyaluronic acid (HA), Procollagen III amino terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase 1 (TIMP-1)—which provide a score, shown to correlate to the level of liver fibrosis as assessed by liver biopsy. In an international multi-centre study with a mix of patient groups, the ELF test was clinically validated and found to be accurate to differentiate mild, moderate and severe fibrosis4.

Microbiology Solutions

Attendees also learnt about Siemens’ latest microbiology offerings, including LabPro Connect, a new software solution that consolidates databases for multiple testing systems. The open-system configuration option delivers workstation networking by aggregating LabPro ID/AST data to bench and laboratory office computers, reducing wasted staff time absorbed by visiting different instruments to collect information. LabPro Connect can also be configured as a closed-system without workstation networking.

Also highlighted were microbiology automation and mass spectrometry solutions now available from Siemens as a result of a recently forged strategic partnership with Copan and co-marketing agreement with Bruker Corporation. The Copan Walk-Away Specimen Processor (WASP® instrument)5 offers fully automated bacteriology specimen processing, individualised sample management, utilising familiar streaking patterns, standardises workflow processes and optimises specimen set-up activities to free up staff resources. The Bruker MALDI Biotyper6 provides faster, more accurate and very cost-effective molecular microorganism identification using MALDI-TOF mass spectrometry for proteomic fingerprinting. This technology provides faster TTR, along with outstanding accuracy and sensitivity, to meet the demands of diverse laboratory needs.

Molecular Solutions

Additionally, Siemens’ ECCMID booth included information about the VERSANT® HCV RNA 1.0 Assay, a highly sensitive viral load assay for the VERSANT kPCR Molecular System7. This assay aids in the management of individuals infected with hepatitis C (HCV)—one of the main causes of chronic liver disease worldwide8— who are undergoing antiviral therapy. This assay provides outstanding precision across the dynamic range and 100% specificity with a 95% lower confidence limit of 99.7%, and features technology that is compatible with all HCV genotypes.

Visitors also found out about TRUGENE® HIV-1 GuideLines™ 17.09, the latest interpretive algorithm for HIV-1 drug resistance, which are clinically validated and updated annually by an independent expert panel, as well as the company’s latest tissue preparation and extraction solutions to maximise lab efficiency.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!